Metis Global Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,331	Closed	-$289K	–	769
2025 Q3	$289K	Sell	5,331 -229	-4%	-$13.1K	0.01%	673
2025 Q2	$306K	Sell	5,560 -1,310	-19%	-$77.1K	0.01%	657
2025 Q1	$486K	Buy	6,870 +1,184	+21%	+$79.7K	0.01%	597
2024 Q4	$374K	Buy	5,686 +236	+4%	+$15.8K	0.01%	627
2024 Q3	$383K	Buy	5,450 +480	+10%	+$40.1K	0.01%	624
2024 Q2	$409K	Buy	4,970 +83	+2%	+$6.91K	0.01%	586
2024 Q1	$427K	Buy	4,887 +15	+0.3%	+$1.34K	0.02%	591
2023 Q4	$470K	Sell	4,872 -245	-5%	-$21.7K	0.02%	558
2023 Q3	$453K	Buy	5,117 +214	+4%	+$19K	0.02%	551
2023 Q2	$425K	Buy	4,903 +519	+12%	+$48.8K	0.02%	552
2023 Q1	$426K	Buy	4,384 +1,811	+70%	+$188K	0.03%	517
2022 Q4	$266K	Buy	+2,573	New	+$242K	0.02%	552